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Abstract
Cytauxzoonosis is an emerging infectious disease of domestic cats (Felis catus) caused by the apicomplexan protozoan
parasite Cytauxzoon felis. The growing epidemic, with its high morbidity and mortality points to the need for a protective
vaccine against cytauxzoonosis. Unfortunately, the causative agent has yet to be cultured continuously in vitro, rendering
traditional vaccine development approaches beyond reach. Here we report the use of comparative genomics to
computationally and experimentally interpret the C. felis genome to identify a novel candidate vaccine antigen for
cytauxzoonosis. As a starting point we sequenced, assembled, and annotated the C. felis genome and the proteins it
encodes. Whole genome alignment revealed considerable conserved synteny with other apicomplexans. In particular,
alignments with the bovine parasite Theileria parva revealed that a C. felis gene, cf76, is syntenic to p67 (the leading vaccine
candidate for bovine theileriosis), despite a lack of significant sequence similarity. Recombinant subdomains of cf76 were
challenged with survivor-cat antiserum and found to be highly seroreactive. Comparison of eleven geographically diverse
samples from the south-central and southeastern USA demonstrated 91–100% amino acid sequence identity across cf76,
including a high level of conservation in an immunogenic 226 amino acid (24 kDa) carboxyl terminal domain. Using in situ
hybridization, transcription of cf76 was documented in the schizogenous stage of parasite replication, the life stage that is
believed to be the most important for development of a protective immune response. Collectively, these data point to
identification of the first potential vaccine candidate antigen for cytauxzoonosis. Further, our bioinformatic approach
emphasizes the use of comparative genomics as an accelerated path to developing vaccines against experimentally
intractable pathogens.
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Introduction
Cytauxzoon felis is a protozoan parasite of felids that causes
cytauxzoonosis, an emerging disease in domestic cats. Without
treatment nearly all cats die within three to five days of the onset of
clinical symptoms. There are currently no effective means to
prevent cytauxzoonosis, and even with treatment costing thou-
sands of dollars, up to 40% of cats still succumb [1,2]. First
described in Missouri in 1976, the geographic range of C. felis is
expanding and it has now been diagnosed in domestic cats in one
third of US states (Figure 1) [1,3,4,5,6,7,8,9,10,11]. Expansion of
the geographic range is presumed to be due to changes in climate,
urbanization, and increased exposure to the bobcat [Lynx rufus]
reservoir host and the tick vector [Amblyomma americanum]. Bobcats
experience a transient schizogenous tissue phase of limited
pathogenicity followed by chronic erythroparasitemia. In domestic
cats, the disease is usually characterized by a lethal acute
schizogenous tissue phase. For animals that survive, a fairly
innocuous chronic erythroparasitemia ensues (Figure 2). The high
mortality, growing epidemic and cost of care point to vaccination
as the most practical control strategy. Prior studies documenting
the development of a protective immune response against C. felis
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imply that vaccine development is feasible [12,13,14,15]. However
the inability to culture C. felis in vitro has been a major barrier to
discovery of protective antigens [14], and no vaccines against C.
felis exist. In order to overcome experimental limitations and
facilitate the rapid identification of vaccine candidate antigens we
sequenced the entire 9.1 Mbp C. felis genome and identified
approximately 4,300 protein-coding genes, each of which repre-
sents a potential protective antigen.
We used leading vaccine candidates from other apicomplexans
as a guide to search for orthologues within the C. felis gene
complement. Cytauxzoon felis is closely related to the apicomplexans
Theileria parva and Theileria annulata, the etiologic agents of East
Coast fever (ECF) and tropical theileriosis in cattle, respectively
[16,17,18]. The leading vaccine candidate for T. parva, p67, has
conferred substantial protection against ECF in clinical trials.
Immunization of cattle with p67 reduced the incidence of severe
ECF by 49% during field tick challenge trials in Kenya [19]. The
T. annulata homologue of p67, SPAG-1, includes neutralizing
epitopes on the carboxy terminus that are cross-reactive with p67,
and SPAG-1 has been shown to confer protection to homologous
species challenge [20,21]. The functions of p67 and SPAG-1 have
not been definitively identified although they are proposed to be
involved in host cell recognition and invasion [20,22].
Although T. parva p67 shares only 47% amino acid sequence
identity with SPAG-1 [23], these two loci reside within a syntenic
block of genes highly conserved between the two Theileria species,
consistent with their orthology. We searched for C. felis
orthologues of p67 and SPAG-1 but found no sequences with
significant amino acid similarity. Therefore, guided by the
approach used to identify the p67/SPAG-1 orthologue in Babesia
bovis (BOV57), we used conserved genome synteny to expose the
C. felis orthologue of p67/SPAG-1, which we call cf76 [24]. Here
we report our assessment of three criteria likely to be important in
determining suitability of cf76 as a vaccine candidate: 1)
recognition by the feline immune system 2) degree of sequence
similarity among C. felis isolates and 3) expression in the C. felis life
stage that is believed to be critical for the development of a
protective immune response.
Materials and Methods
Sequence and assembly of the Cytauxzoon felis genome
and comparison of the C. felis genome with related
apicomplexans
Whole blood (80 ml) was collected by sterile methods into
citrate phosphate dextrose adenine (CPDA-1) anticoagulant
immediately post-mortem from a domestic cat that died of acute
C. felis infection. Acute infection was confirmed by microscopic
observation of numerous C. felis schizonts in tissue imprints of liver,
lung, and spleen. The blood was leuko-reduced to remove host
nucleic acid contamination and isolate merozoite infected
erythrocytes using a Purecell NEO Neonatal High Efficiency
Leukocyte Reduction Filter for Red Cell Aliquots (PALL Corp.,
Port Washington, NY). Cytauxzoon felis genomic DNA was purified
from leuko-reduced blood using the QIAamp DNA Blood Mini
Kit (Qiagen, Valencia, CA).
We sequenced the C. felis genome using a 454 Genome
Sequencer FLX (Roche, Indianapolis, IN) with Titanium chem-
istry and the standard Roche protocol. The sequence was
Figure 1. Distribution of cytauxzoonosis in the United States.
doi:10.1371/journal.pone.0071233.g001
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assembled using Newbler 2.0 with a minimum overlap require-
ment of 90% identity over 30 bases. Resulting contigs were
compared to the Felis catus genome and contaminating cat
sequences (,2% of total reads) were removed.
Cytauxzoon felis tRNA and mRNA were isolated from purified
merozoites. Whole blood (80 ml) was collected and leuko-reduced
as described above. Following leuko-reduction, erythrocytes were
lysed and tRNA and mRNA were purified using the Ribopure
Blood Kit and PolyAPurist Mag Kit respectively (Ambion, Grand
Island, NY) [25]. A cDNA library was constructed using the
SMARTer PCR cDNA Synthesis Kit (Clontech, Mountain View,
CA) and generation of expressed sequence tags (ESTs) was
completed using a 454 Genome Sequencer FLX (Roche,
Indianapolis, IN) with Titanium chemistry and the standard
Roche protocol. ESTs were assembled with Newbler and the EST
assembly was aligned to the genome using GeneDetective (Time
Logic, Carlsbad, CA).
GeneMark-ES 2.5 (http://exon.gatech.edu/genemark_prok_
gms_plus.cgi), which utilizes a Gibbs sampling algorithm to self-
train for gene prediction, was deployed to create an initial
computationally derived proteome. A combination of hand
curated EST data and GeneMark results were used to create a
training set for GlimmerHMM (http://www.cbcb.umd.edu/
software/glimmer) to provide a second predicted proteome.
Results from the EST comparisons, GlimmerHMM and Gene-
Mark as well as sequence similarity searches against protein data
from B. bovis, T. parva, P. falciparum and NCBI’s non-redundant
protein dataset were integrated into a generic Genome Browser
(GBrowse). The C. felis genome and EST sequences are deposited
with NCBI under BioProject PRJNA196611.
Predicted protein coding genes shared in common amongst the
different organisms was determined. These were deduced by an
all-against-all blastp search. Matches with at least 60% similarity
across at least 30% of the query protein were accepted as matches.
Proteins shared between multiple species were calculated based on
the intersection of protein identifiers in pair-wise comparisons. No
attempts were made to collapse paralogues.
Figure 2. Life cycle of Cytauxzoon felis. The acute tissue stage of disease (the schizogenous phase) is characterized by wide spread dissemination
of schizonts which form parasitic thrombi throughout the body resulting in a disease course that is typically fatal. Hosts that survive this acute tissue
phase develop a chronic yet fairly innocuous erythroparasitemia with merozoite-infected red cells.
doi:10.1371/journal.pone.0071233.g002
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Identification and amplification C. felis cf76
A C. felis gene, cf76 (GenBank Accession KC986871), syntenic
to p67/SPAG-1/BOV57 was identified in silico. p67, SPAG-1, and
BOV57 are each located downstream of the same three highly
conserved genes and upstream of the same two highly conserved
genes (Figure 3). A BLAST search was used to identify the same
highly conserved genes upstream and downstream of cf76. Amino
acid and nucleotide alignments of cf76, p67, SPAG-1, and BOV57
were performed using clustalW [26]. Total RNA was extracted
from C. felis merozoite and schizont-laden splenic tissue collected
immediately post-mortem from a domestic cat that died of acute
C. felis infection using the Trizol LS reagent (Sigma, St. Louis,
MO), following the manufacturer’s methods. Total RNA (10 mg/
reaction) was treated twice with DNA-free DNase Treatment and
Removal Reagent (Ambion, Grand Island, NY). Prior to
generation of cDNA, the absence of contaminating DNA in the
purified RNA was confirmed by PCR for C. felis 18S rRNA genes
[3]. Cytauxzoon felis cDNA was produced using random hexamer
primers (Promega, Madison WI) and Smartscribe reverse
transcriptase (Clontech, Mountain View, CA). PCR to amplify
the C. felis syntenic gene ORF with primers designed from the
predicted flanking sequences was performed using previously
published conditions with 25 pmol each of primer (59 ATTGGA-
TAGTAAATTAGGTTATAAG 39 and 59 GGAATTAATT-
CAGTTGGAATTTG 39) and template (50 ng of C. felis splenic
RNA, 1 ml of C. felis splenic cDNA, 16 ng of C. felis gDNA, or 1 ml
of water) [3]. PCR products were analyzed by agarose gel
electrophoresis. Identification of potential signal sequence and
trans-membrane domains were deduced using Signal P Server
v.4.0 and TMHMM Server v.2.0 from the Center for Biological
Sequence Analysis. The GPI-anchor predictor PredGPI was
employed to predict GPI-anchored protein sequence.
Cloning and in vitro expression of cf76 and cf76
fragments
The cf76 ORF (2172 bp) and three overlapping subdomains of
cf76 including the N-terminal region (720 bp), the central region
(828 bp), and the C-terminal region (675 bp) were amplified from
C. felis cDNA using primer pairs (Table 1) with a 20 bp adapter
sequence at the 59 and 39 ends homologous to cloning sites of a
linearized acceptor vector pXT7, to allow for directional cloning.
PCR was performed with previously published conditions using
0.05 U/ml High Fidelity Expand Plus Taq DNA polymerase
(Roche, Indianapolis, IN), 25 pmol of each primer (Table 1), and
5 ng of C. felis cDNA template [27,28,29].
Each amplified cf76 PCR product was cloned into a pXT7
vector containing an N-terminus 106histidine (HIS) tag and a C-
terminus hemagglutinin (HA) tag using homologous recombina-
tion as previously described [27,28,29] and all clones were
sequenced bi-directionally. In vitro transcription and translation
reactions (IVTT) were performed with purified recombinant
plasmids using the RTS 100 E. coli HY kit (5 PRIME,
Gaithersburg, MD).
Purification of cf76 and cf76 subdomains
IVTT reaction components containing the entire cf76 protein
and cf76 subdomains were purified using the N-terminal HIS tag
under native and denaturing conditions with Qiagen Ni-NTA
Magnetic Agarose Beads (Qiagen, Valencia, CA). Purity and
quantity was assessed by western blot analysis in duplicate using
secondary antibodies against the N-terminal HIS tag and the C-
terminal HA tag using mouse anti-poly-HIS monoclonal IgG2a
antibody or mouse anti-poly-HA monoclonal antibody (Anti-His6
(2) and anti-HA clone 12CA5 respectively (Roche, Indianapolis,
IN) as described below.
SDS-PAGE and immunoblot analysis
cf76 and cf76 subdomain IVTT reactions and purified proteins
were analyzed by western blot analysis. Proteins were subjected to
SDS-PAGE (4–12% Bis-Tris Gel NuPAGE, Invitrogen, Grand
Island, NY) and transferred onto polyvinylidene fluoride (PVDF)
membranes (Millipore, Billerica, MA). After blocking (16 phos-
phate buffered saline containing 0.05% (v/v) Tween-20 (PBST),
2% nonfat milk, 2% bovine serum albumin (BSA), 2% gelatin
from cold water fish skin for 1 h at room temperature, membranes
were incubated with mouse anti-poly-HIS monoclonal antibody or
mouse anti-poly-HA monoclonal antibody (Anti-His6 (2) and anti-
HA clone 12CA5; Roche, Indianapolis, IN) overnight at 4uC.
After three consecutive washes for 5 min at room temperature in
PBST, membranes were incubated with horse radish peroxidase
(HRP) conjugated goat anti-mouse immunoglobulin (H+L IgG;
Biorad, Hercules, CA) at room temperature for 1 h and washed
36 with PBST at room temperature. Immobilon Western
Chemiluminescent HRP Substrate (Millipore, Billerica, MA) was
used for signal detection.
The immune response to purified cf76 and cf76 subdomains
was assessed by western blotting using pooled sera from 10
domestic cats that survived natural C. felis infection, as well as 10
na¨ive cats. To determine C. felis infection status, genomic DNA
(gDNA) was purified using the QIAamp DNA Blood Mini Kit
(Qiagen, Valencia, CA) and real-time PCR for C. felis 18S and for
the feline house-keeping gene GAPDH was performed using
previously published methods [3,30]. Western blots of purified
protein were prepared and blocked as described with the addition
of 5% goat serum. Cat sera was diluted 1:500 in blocking buffer
containing 1.5 mg/ml E. coli lysate (MCLAB, South San
Francisco, CA) and incubated for 2 h at room temperature to
adsorb E. coli binding proteins in feline sera that may contribute to
background. Membranes were incubated with pre-adsorbed cat
sera for 2 h at room temperature, washed 565 min in PBST,
Figure 3. Conserved gene synteny between T. parva p67 and C. felis cf76. cf76 is identified in silico within a highly conserved syntenic block
of genes similarly to the leading vaccine candidate for T. parva, p67.
doi:10.1371/journal.pone.0071233.g003
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incubated for 1 h at room temperature with goat anti-cat HRP
antibody (H+L IgG; Jackson ImmunoResearch, West Grove, PA),
washed 565 min in PBST, and a chemiluminescent signal was
detected with a luminometer (Perkin Elmer, Massachusetts, NY).
Conservation of cf76 sequence from diverse geographic
regions
Genomic DNA was extracted from 11 C. felis infected whole
blood samples collected from geographically diverse regions using
QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA). cf76 was
amplified by PCR under the following conditions: 0.05 U/ml High
Fidelity Expand Plus Taq DNA polymerase (Roche, Indianapolis,
IN), 0.2 mM of each dNTP, 16 reaction buffer, 25 pmol of each
primer (FOR- 59 ATTGGATAGTAAATTAGGTTATAAG 39
and REV- 59 GGAATTAATTCAGTTGGAATTTG 39), 5 ml
gDNA, initial denaturation at 95uC for 5 min; 40 cycles of 95uC
for 30 sec, 54uC for 1.5 min, and 72uC for 2 min; and a final
extension at 72uC for 10 min. The cf76 sequences from these
samples (GenBank Accessions KC986861–KC986871) and se-
quences from B. bovis (BOV57, GenBank FJ805276.1,
ACY08791.1), T. parva (p67, GenBank U40703.1, AAB06703.1)
and T. annulata (SPAG-1, GenBank M63017.1, AAA30134.1) were
aligned (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
For tree construction, DNA sequences for the 11 cf76 sequences
were aligned using ClustalX [26]. Phylogenetic reconstruction was
performed via MrBayes [31] using a GTR model with gamma-
distributed rate variation across sites. A total of 100,000
generations were run on 2 chains with a sample frequency of
100. A burn-in of 100 data points was more than sufficient to
reach convergence.
Transcription of cf76 in schizonts
C. felis infected lung tissues were harvested and formalin fixed
immediately post-mortem from a cat that died of acute
cytauxzoonosis. Hematoxylin and eosin (H&E) stained sections
were examined for the presence of schizonts. The C-terminal
region (678 bp) of cf76 was amplified by PCR, cloned into the
pGEM-T Easy vector (Promega, Madison, WI) and sequenced bi-
directionally. A negative sense digoxigenin-labeled riboprobe was
generated and in situ hybridization was performed as previously
described on infected lung tissue including the use of an non-
specific (avian viral pathogen derived sequence) digoxigenin-
labeled negative sense probe [32].
Ethics Statement
This study was conducted in strict accordance with the
recommendations of North Carolina State University Institutional
Animal Care and Use Committee (NCSU IACUC) approved
protocol 09-067-O. The samples used for this publication were either
scheduled to be discarded from of a previous study (collected with
owner consent under NCSU IACUC approved protocol 09-067-O)
or were diagnostic samples that were scheduled to be discarded.
Results and Discussion
Sequence and assembly of the Cytauxzoon felis genome
and comparison of the C. felis genome with related
apicomplexans
The C. felis sequence assembled into 361 contigs spanning 9.1
mega-bases (MB) of genomic DNA post decontamination of F.
Table 1. Primer sequences for amplification of cf76.
Primer Sequence Product
cf76 Forward ORF 59 ACGACAAGCATATGCTCGAG- ATGAAATTTTTATTAATGTTTGTGGTGCCTTTG 39 Full length cf76 (2172 bp)
cf76 Reverse ORF 59 TCCGGAACATCGTATGGGTA- AACTAGTGTTAATGATAACAATAATGTAGC 39 Full length cf76 (2172 bp)
cf76 Forward Fragment 1 59 ACGACAAGCATATGCTCGAG-ATGAAATTTTTATTAATGTTTGTGGTGCCTTTG 39 N-terminal region (720 bp)
cf76 Reverse Fragment 1 59 TCCGGAACATCGTATGGGTA- TTCCACTTGAGGTCCAGTGACTATAC 39 N-terminal region (720 bp)
cf76 Forward Fragment 2 59 ACGACAAGCATATGCTCGAG-GATCGTGGCGGAAGTATAGTCACTG 39 Central region (828 bp)
cf76 Reverse Fragment 2 59 TCCGGAACATCGTATGGGTA- AGCTATTGAATGTTCTTCTTGTAATGAATT 39 Central region (828 bp)
cf76 Forward Fragment 3 59 ACGACAAGCATATGCTCGAG-GAAGAACATTCAATAGCTAATTCATTA 39 C-terminal region (675 bp)
cf76 Reverse Fragment 3 59 TCCGGAACATCGTATGGGTA- AACTAGTGTTAATGATAACAATAATGTAGC 39 C-terminal region (675 bp)
doi:10.1371/journal.pone.0071233.t001
Table 2. Sequence assembly of Cytauxzoon felis genomic and cDNA.
Genomic ESTsa
Raw Reads 603,160 202,774
Feline Contamination (%) 4.9 53.9
C. felis Contigs 361 962
Total # Bases in Contigs 9,110,259 547,540
Largest Contig (bp) 183,236 4,132
Contig N50b 70,451 639
G+C Composition (%) 31.8 36.2
aExpressed Sequence Tags.
bThe contig length such that using equal or longer contigs produces half the bases of the assembly.
doi:10.1371/journal.pone.0071233.t002
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catus sequence (Table 2). The largest contiguous stretch of genomic
sequence was 183 kb, with an N50 of greater than 70 kb. This
genomic data was used to establish an initial computationally
predicted proteome of 4,323 genes using the self-training program
GeneMark.hmm-ES (v2.5).
The C. felis EST data assembled to 962 contigs covering 547 kb
of gene space (Table 2). These contigs were used in a BLASTX
search against the NCBI non-redundant database to identify
contigs that likely represent close to full-length genes. A
GeneDetective search of the ESTs against the genomic data
provided information about gene structure (Time Logic, Carlsbad,
CA).
A set of 100 randomly selected GeneMark predictions and 57
hand-curated full-length ESTs were then used as a training set for
GlimmerHMM (v.3.02). Based on that training set, Glim-
merHMM predicted 4,378 genes (Table 3). Although there was
some slight variation between the two computationally derived
gene sets (Table 3), approximately 25% of the genes are identical
between the two, and a further 50% differ only in ascribing the
most 59 or most 39 exons; such discrepancies were typically
straightforward to resolve with manual curation.
In comparing the C. felis genome (GenBank Accession
PRJNA196611) to the genomes of three related apicomplexans,
T. parva (GenBank Accession PRJNA16136), B. bovis (GenBank
Accession PRJNA20343) and P. falciparum (GenBank Accession
PRJNA148) attributes such as genome size, %GC content, average
protein length and number of protein-coding genes most closely
resemble T. parva and are most different from P. falciparum
(Table 3). A comparison of predicted genes between these sets
reveals more similar genes in common with T. parva. A total of 914
similar genes are present in all four apicomplexans, and 2,420 are
shared by C. felis, B. bovis and T. parva but are not found in P.
falciparum. Note that the numbers in each sector of the Venn
Diagram are not strictly additive due to the variation in size of
different gene families within each of the respective genomes, but
provide an overall indication as to the relatedness between the
organisms as a whole (Figure S1).
Identification and characterization of C. felis cf76
Given that C. felis is most closely related to Theileria spp, a
BLAST search was used to identify a C. felis orthologue to p67/
SPAG-1. However, no C. felis genes with significant identity to p67
or SPAG-1 were identified within the C. felis genome. Therefore
we used genome synteny as a guide, and identified a 2172 bp
single copy C. felis gene syntenic to p67. Theileria parva p67, T.
annulata SPAG-1, and B. bovis BOV57 antigens are encoded by
genes that reside within a syntenic block that is highly conserved
between the three species and a similar syntenic block of C. felis
genes was identified in silico (Figure 3). cf76, p67, SPAG-1, and
BOV57 are 723aa, 752aa, 907aa, and 494aa in length respec-
tively. The C. felis isolate submitted for genome sequencing was
slightly larger than that of the majority of geographically diverse
isolates sequenced which were approximately 706aa. Similar to
BOV57, cf76 contains a single exon, while p67 and SPAG-1
contain two exons. Consistent with the BLAST result, cf76 only
shared 22%, 23%, and 23% nucleotide identities with p67, SPAG-
1, and BOV57 respectively (Figure S2) and 13%, 13%, and 14%
amino acid similarities with p67, SPAG-1, and BOV57 (Figure
S3). Based on the mean predicted molecular weight across isolates
Table 3. Comparison of gene predictions of the Cytauxzoon felis genome with related apicomplexans.
C. felis T. parva23 B. bovis23 P. falciparum23
GeneMark Glimmer
Genome Size (Mbp) 9.1 9.1 8.3 8.2 22.8
G+C Composition (%) 31.8 31.8 34.1 41.8 19.4
Protein Coding Genes 4,323 4,378 4,061 3,706 5,337
Average Protein (aa) 466 409 469 505 761
% Genes with Introns 68.7 61.7 73.6 61.5 53.9
Protein Coding (%) 66.2 68.8 68.4 70.2 52.6
doi:10.1371/journal.pone.0071233.t003
Figure 4. Assessment of feline sero-reactivity to cf76 and cf76 fragments by western blot. Purified full length cf76 (1), the N-terminal
region (2), the central region (3), and the C-terminal region (4) were probed with pooled sera (1:500) from cats surviving C. felis infection (A) or naive
cats (B).
doi:10.1371/journal.pone.0071233.g004
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sequenced (75,557.78 Da) we designated the gene that is syntenic
to p67/SPAG-1/BOV57 as cf76.
Similar to p67, SPAG-1, and BOV57, cf76 encodes a protein
with a predicted signal peptide sequence at the amino terminus,
suggesting that this protein may be secreted. In contrast to p67/
SPAG-1, cf76 does not have a transmembrane domain, suggesting
that it is unlikely to be membrane bound. Also unique to cf76 is a
putative glycosylphosphatidylinositol (GPI) anchor. GPI anchors
are glycolipids that anchor membrane proteins and have been
associated with immunoreactivity in some protozoan pathogens
[33]. While it is difficult to definitively establish orthology of cf76
with p67/SPAG-1 using sequence identity, we speculate that
conserved synteny combined with a lack of conserved sequence
identity may indicate an orthologous gene that is under extreme
pressure from the host immune response.
Feline humoral immune response to recombinant cf76
Western blot analysis using pooled sera from 10 cats surviving
C. felis infection revealed strong seroreactivity to HIS-purified
recombinant cf76 and the C-terminal region. In comparison,
lower intensity signal was detected against the central and N-
terminal regions of cf76 with immune sera. Substantial reactivity
was not observed using pooled sera from 10 cats that tested
negative for C. felis, and observed signal was attributed to low levels
of cross-reacting antibodies unrelated to C. felis infection (Figure 4).
The apparent molecular mass of full length cf76, the N-terminal
region, the central region, and the C-terminal region were
approximately 100 kDa, 42 kDa, 35 kDa and 37 kDa, despite
predicted molecular mass of 81.6 kDa, 27.1 kDa, 33 kDa, and
26.8 kDa respectively (Figure 5). Production and co-purification of
partial transcripts as well as putative degradation products were
observed for western blots probed with anti-HIS antibodies while
only complete proteins were observed on blots probed with anti-
HA antibodies. Collectively these data support that the C-terminus
of cf76 is highly immunogenic during natural infection with C. felis.
Future experiments evaluating sera from individual cats will
provide more information on the percentage of cats surviving C.
felis infection that have robust antibody responses against cf76.
cf76 sequence is conserved between samples from
different geographic regions
In order to assess the degree of conservation amongst C. felis
parasite samples from different geographic regions, we amplified
and sequenced cf76 from eleven different samples from eight states
in the southeastern and south-central United States, revealing a
high degree of conservation (92.2 to 100% identity) (Figure S4).
Evidence of phylogenetic divergence is seen between the isolates
obtained from the two states furthest east (NC and VA) and the
other states (Figure S5). Preliminary epitope mapping revealed
that high levels of feline antibodies are developed against linear
epitopes present in the C-terminal region (Figure 4). This region is
highly conserved amongst samples. The only variation in this
region was that ten of eleven samples had a tandem repeat of
30 bp sequence while the remaining sample only had this 30 bp
sequence once.
cf76 is expressed in the C. felis life-stage associated with
immune protection
Cytauxzoon spp. has a complex life cycle with three life stages in
the mammalian host: sporozoites, schizonts, and merozoites
(Figure 2). Of these, schizonts have been associated with a
protective immune response. Solid immunity to C. felis was
observed in cats that had previously survived the schizogenous
phase of cytauxzoonosis [12,14,34]. These cats survived challenge
infection with no signs of illness while naı¨ve control cats died of
cytauxzoonosis. In contrast direct inoculation with C. felis
merozoites alone has not conferred protective immunity. Collec-
tively, these data suggest antigens associated with schizonts are
vaccine targets for C. felis. Based on these findings we investigated
expression of cf76 in the schizont stage of C. felis using in situ
hybridization. Using a labeled negative sense riboprobe directed
against cytoplasmic mRNA, we found robust levels of cf76
transcripts in the schizogenous tissue stage of C. felis (Figure 6)
further supporting consideration of this antigen as a vaccine
candidate.
Conclusions
Prior to our work no protein coding genes from C. felis had been
characterized. Based on a full genome sequence we have now
identified ,4,300 protein coding genes and characterized the first
vaccine candidate for C. felis. Specifically, our work demonstrates
Figure 5. Assessment of purified cf76 and cf76 fragments by
western blot. Purified full length cf76 (1), the N-terminal region (2),
the central region (3), and the C-terminal region (4) were probed with
anti-HIS N-terminal tag (A) and anti-HA C-terminal tag antibodies (B).
doi:10.1371/journal.pone.0071233.g005
Figure 6. In situ hybridization to identify transcription of cf76 in C. felis-infected lung tissue. A. Hematoxylin and eosin stained lung
tissue demonstrating schizonts forming a parasitic thrombus within a pulmonary vessel, 20X, B. Negative sense riboprobe, hematoxylin and eosin
counterstain, numerous positive cells (brown) are demonstrating intracytoplasmic presence of cf76 antigen, 20X, C. Irrelevant negative sense
riboprobe, hematoxylin and eosin counterstain, 20X.
doi:10.1371/journal.pone.0071233.g006
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the potential of cf76 as a vaccine candidate antigen for
cytauxzoonosis as it is: 1) recognized by the feline humoral
immune system, 2) highly conserved amongst isolates and 3)
transcribed in the life stage of C. felis shown to confer protective
immunity. To substantiate the efficacy of cf76 as a vaccine antigen,
significant reduction in morbidity and mortality of cytauxzoonosis
must be demonstrated in immunization and challenge trials.
Our bioinformatic approach provides an example of how
comparative genomics can provide an accelerated path to identify
vaccine candidates in experimentally intractable pathogens. In
addition to identification of specific candidate genes, this approach
provides a valuable resource for future comparative genomic and
proteomic studies to accelerate identification of additional vaccine
candidates and drug targets for C. felis and related apicomplexans.
Supporting Information
Figure S1 Four way Venn Diagram: Protein coding
genes of Cytauxzoon felis and related apicomplexan
parasites.
(TIF)
Figure S2 Nucleotide sequence alignment of syntenic
genes C. felis cf76-1 (isolate from the C. felis genome
sequence), cf76-2 (the most common sequence among
eleven geographically diverse C. felis isolates), T. parva
p67 (GenBank U40703.1), T. annulata SPAG-1 (GenBank
M63017.1), and B. bovis BOV57 (GenBank FJ805276.1).
(DOC)
Figure S3 Amino acid sequence alignment of syntenic
genes C. felis cf76-1 (isolate from the C. felis genome
sequence), cf76-2 (the most common sequence among
eleven geographically diverse C. felis isolates), T. parva
p67 (GenBank AAB06703.1), T. annulata SPAG-1 (Gen-
Bank AAA30134.1), and B. bovis BOV57 (GenBank
ACY08791.1) (shading: black- identical amino acids,
grey- similar amino acids).
(DOC)
Figure S4 Amino acid sequences of syntenic gene C.
felis cf76 from geographic isolates across the southeast-
ern and southwestern United States (shading: black-
identical amino acids, grey- similar amino acids).
(DOC)
Figure S5 Phylogenetic reconstruction of cf76 across 11
isolates. Posterior probability of clades is indicated on branches.
Sample names are based on the name of the individual animal and
the state from which the sample was taken (AR - Arkansas, KS -
Kansas, MO - Missouri, NC - North Carolina, OK - Oklahoma,
OH - Ohio, TN - Tennessee, VA - Virginia). Scale bar indicates
expected changes per site. Full genome sequence is derived from
Winnie-VA.
(TIF)
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